Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Viremia D014766 4 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Bronchiectasis D001987 7 associated lipids
Anthrax D000881 1 associated lipids
Heart Injuries D006335 6 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Logan JE and Roudebush WE Platelet-activating factor increases intracellular calcium levels in preimplantation stage embryos. 2000 Early Pregnancy pmid:11719820
Claman P Platelet activating factor does not improve intrauterine insemination outcome. 2001 Am. J. Obstet. Gynecol. pmid:11717679
Macphee CH Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target. 2001 Curr Opin Pharmacol pmid:11714085
Suwaki T et al. Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug. 2001 Int. Immunopharmacol. pmid:11710545
Ibe BO et al. Maturational changes in ovine pulmonary metabolism of platelet-activating factor: implications for postnatal adaptation. 2001 Mol. Genet. Metab. pmid:11708870
Bernatchez PN et al. Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways. 2001 Br. J. Pharmacol. pmid:11704645
Masuhara K et al. Involvement of platelet activation in experimental osteonecrosis in rabbits. 2001 Int J Exp Pathol pmid:11703540
Adams JM et al. Entry of gut lymph into the circulation primes rat neutrophil respiratory burst in hemorrhagic shock. 2001 Crit. Care Med. pmid:11700422
Houghton TJ et al. Efficient assembly of the phomactin core via two different macrocyclization protocols. 2001 Org. Lett. pmid:11700095
Lendvai B et al. Platelet-activating factor evokes Ca2+ transients after the blockade of ryanodine receptor by dantrolene in RAW 264.7 macrophages. 2001 Neurochem. Res. pmid:11699928
Casao MA et al. Promotion of platelet aggregation by sera from brucellosis patients with antiphosphatidylcholine antibodies. 2001 J. Med. Microbiol. pmid:11699593
Kaul DK et al. Ameliorating effects of fluorocarbon emulsion on sickle red blood cell-induced obstruction in an ex vivo vasculature. 2001 Blood pmid:11698300
den Dekker E et al. Biogenesis of G-protein mediated calcium signaling in human megakaryocytes. 2001 Thromb. Haemost. pmid:11686331
Marathe GK et al. Oxidized LDL contains inflammatory PAF-like phospholipids. 2001 Apr-May Trends Cardiovasc. Med. pmid:11686003
Dutra PM et al. Platelet-activating factor modulates a secreted phosphatase activity of the trypanosomatid parasite Herpetomonas muscarum muscarum. 2001 Curr. Microbiol. pmid:11683365
Wielockx B et al. Involvement of a serine protease, but not of neutrophil elastase, in tumor necrosis factor-induced lethal hepatitis and induction of platelet-activating factor. 2001 J. Hepatol. pmid:11682033
Pettorossi VE and Grassi S Different contributions of platelet-activating factor and nitric oxide in long-term potentiation of the rat medial vestibular nuclei. 2001 Acta Otolaryngol Suppl pmid:11677732
Kohno S and Nabe T [Inflammatory mediators (leukotrienes, thromboxane A2, tachykinins and others)]. 2001 Nippon Rinsho pmid:11676130
Camici M and Sagripanti A Plasma platelet activating factor in nephrotic syndrome. 2001 Minerva Med. pmid:11675576
Storey RF et al. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood. 2001 Platelets pmid:11674863
Berdyshev EV et al. Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. 2001 FASEB J. pmid:11641243
Fabi F et al. Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways. 2001 Br. J. Pharmacol. pmid:11606318
Tsai MH et al. Effect of platelet activating factor and butyrate on the expression of interleukin-2 receptor alpha in nasopharyngeal carcinoma cells. 2001 Int. J. Oncol. pmid:11605008
Yu P et al. [Pathogenetic effect of platelet activating factor on enterogenic endotoxemia after burn]. 1999 Zhonghua Yi Xue Za Zhi pmid:11601022
Havt A et al. The renal effects of Bothrops jararacussu venom and the role of PLA(2) and PAF blockers. 2001 Toxicon pmid:11600146
Mathison R et al. Regulation of leukocyte adhesion to heart by the tripeptides feG and feG(NH2). 2001 Can. J. Physiol. Pharmacol. pmid:11599779
Sirolli V et al. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis. 2001 Thromb. Haemost. pmid:11583316
Jolly S et al. Effect of intravenous platelet-activating factor on bovine pulmonary mast cells. 2001 Aug-Oct J. Comp. Pathol. pmid:11578122
Christie PE and Henderson WR Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor. 2002 Clin Allergy Immunol pmid:11577541
Mariano F et al. Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. 2001 Kidney Int. pmid:11576379
Khoo C et al. Inhibition of store-operated Ca(2+) influx by acidic extracellular pH in cultured human microglia. 2001 Glia pmid:11571781
Bhatia M et al. Inflammatory mediators as therapeutic targets in acute pancreatitis. 2001 Curr Opin Investig Drugs pmid:11566005
McKenna DJ et al. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. 2001 Sep-Oct Altern Ther Health Med pmid:11565403
Zhao L et al. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro. 2001 Br. J. Pharmacol. pmid:11564653
Tsai JJ and Wang TF Different densities of human eosinophils respond differently to PAF and IL-5. 1999 J Microbiol Immunol Infect pmid:11561566
Fukunaga K et al. Single nucleotide polymorphism of human platelet-activating factor receptor impairs G-protein activation. 2001 J. Biol. Chem. pmid:11560941
Rozenfeld RA et al. Role of gut flora on intestinal group II phospholipase A2 activity and intestinal injury in shock. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11557516
Kavakli K et al. Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease. 2001 Haemophilia pmid:11554936
Chemler SR et al. Enantioselective synthesis of the oxadecalin core of phomactin A via a highly stereoselective Diels-Alder reaction. 2001 Org. Lett. pmid:11554815
Denizot Y et al. Is there a role of platelet-activating factor in human lung cancer? 2001 Aug-Sep Lung Cancer pmid:11551414
Tokutomi T et al. Production of platelet-activating factor by neuronal cells in the rat brain with cold injury. 2001 Neurol. Res. pmid:11547929
Fazal N et al. PAF receptor antagonist modulates neutrophil responses with thermal injury in vivo. 2001 Am. J. Physiol., Cell Physiol. pmid:11546669
Steer ML Relationship between pancreatitis and lung diseases. 2001 Respir Physiol pmid:11535257
Stafforini DM PAF acetylhydrolase gene polymorphisms and asthma severity. 2001 Pharmacogenomics pmid:11535107
Watanabe S et al. Suppression of platelet-activating factor generation and modulation of arachidonate metabolism by dietary enrichment with (n-9) eicosatrienoic acid or docosahexaenoic acid in mouse peritoneal cells. 2001 Prostaglandins Other Lipid Mediat. pmid:11534547
Thomet OA et al. Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils. 2001 Clin. Exp. Allergy pmid:11529903
Qian C et al. Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor. 2001 Pharmacol. Res. pmid:11529688
McManus LM et al. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. 2001 J. Leukoc. Biol. pmid:11527989
Emingil G et al. Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases. 2001 J. Periodontol. pmid:11525434
Bernatchez PN et al. VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2. 2001 Br. J. Pharmacol. pmid:11522612
Dubois MJ and Vincent JL Clinically-oriented therapies in sepsis: a review. 2000 J. Endotoxin Res. pmid:11521072
Carceller E et al. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity. 2001 J. Med. Chem. pmid:11520209
Hoenstein R et al. Interleukin-2 activates human peripheral blood eosinophils. 2001 Cell. Immunol. pmid:11520078
Smith DG et al. Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. 2001 J. Neurovirol. pmid:11519483
Marathe GK et al. Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. 2001 J. Lipid Res. pmid:11518762
Mooren FC et al. Decoupling of intracellular calcium signaling in granulocytes after exhaustive exercise. 2001 Int J Sports Med pmid:11510867
Feldman C et al. Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro. 2001 Eur. Respir. J. pmid:11510782
Stoddart NR et al. Exogenous platelet-activating factor stimulates cell proliferation in mouse pre-implantation embryos prior to the fourth cell cycle and shows isoform-specific stimulatory effects. 2001 Zygote pmid:11510473
Hourton D et al. Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity. 2001 Eur. J. Biochem. pmid:11502209
Liu Y et al. [The role and significance of PAF in the early pulmonary injury following burns combined with endotoxemia in rats]. 1999 Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi pmid:11501075
Alvarez A and Sanz MJ Reactive oxygen species mediate angiotensin II-induced leukocyte-endothelial cell interactions in vivo. 2001 J. Leukoc. Biol. pmid:11493611
Hu LH et al. Synthesis and biological activity of amide derivatives of ginkgolide A. 2001 J Asian Nat Prod Res pmid:11491398
Coker A et al. Is mannitol effective against platelet-activating factor (PAF)-induced liver damage in obstructive jaundice? 2001 Jul-Aug Hepatogastroenterology pmid:11490817
Jantan I et al. Inhibition of platelet-activating factor receptor binding by aporphine and phenanthrenoid alkaloids from Aromadendron elegans. 2001 Planta Med. pmid:11488464
Sachais BS Platelet-endothelial interactions in atherosclerosis. 2001 Curr Atheroscler Rep pmid:11487452
Hermoso M et al. Platelet activating factor increases ciliary activity in the hamster oviduct through epithelial production of prostaglandin E2. 2001 Pflugers Arch. pmid:11484763
Chang PY et al. Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet-activating factor-like phospholipids. 2001 Circulation pmid:11479258
Zhang J et al. [Experimental study on effect of Buyang Huanwu decoction on arterial blood platelet activating factor content pre- and post-arterial thrombosis of rats]. 1998 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11475720
Akisu M et al. The role of recombinant human erythropoietin in lipid peroxidation and platelet-activating factor generation in a rat model of necrotizing enterocolitis. 2001 Eur J Pediatr Surg pmid:11475112
Velasquez LA et al. PAF receptor and PAF acetylhydrolase expression in the endosalpinx of the human Fallopian tube: possible role of embryo-derived PAF in the control of embryo transport to the uterus. 2001 Hum. Reprod. pmid:11473946
Lane JS et al. Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis. 2001 J. Surg. Res. pmid:11469912
Hollmann MW et al. Local anesthetic effects on priming and activation of human neutrophils. 2001 Anesthesiology pmid:11465548
Raggers RJ et al. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. 2001 Biochem. J. pmid:11463358
Grosman N Similar effects of ether phospholipids, PAF and lyso-PAF on the Ca(2+)-ATPase activity of rat brain synaptosomes and leukocyte membranes. 2001 Int. Immunopharmacol. pmid:11460312
Thom SR et al. Roles for platelet-activating factor and *NO-derived oxidants causing neutrophil adherence after CO poisoning. 2001 Am. J. Physiol. Heart Circ. Physiol. pmid:11454599
Miguel BG et al. Increase of phosphoinositide hydrolysis and diacylglycerol production by PAF in isolated rat liver nuclei. 2001 Prostaglandins Other Lipid Mediat. pmid:11444588
Tsoukatos DC et al. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. 2001 Biochem. J. pmid:11439095
Wang H et al. Platelet-activating factor and endotoxin activate CCAAT/enhancer binding protein in rat small intestine. 2001 Br. J. Pharmacol. pmid:11429396
Virchow JC et al. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. 2001 Clin. Exp. Allergy pmid:11422147
Kulikov VI and Muzya GI Inhibition of human platelet aggregation by amides and ester of salicylic acid with platelet-activating factor analogs. 2001 Biochemistry Mosc. pmid:11421815
Jehle R et al. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia. 2001 Biochim. Biophys. Acta pmid:11420174
Mizuno S et al. Role of PAF in acute liver injury after extended hepatectomy: overexpression of PAF receptor mRNA in Kupffer cells. 2001 Dig. Dis. Sci. pmid:11414308
Briton-Jones C et al. The effects of follicular fluid and platelet-activating factor on motion characteristics of poor-quality cryopreserved human sperm. 2001 J. Assist. Reprod. Genet. pmid:11411433
Burke JR et al. BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models. 2001 J. Pharmacol. Exp. Ther. pmid:11408565
Roudebush WE Role of platelet-activating factor in reproduction: sperm function. 2001 Asian J. Androl. pmid:11404790
Tong N et al. Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. 2001 Eur. J. Neurosci. pmid:11403684
Tiemann U et al. Platelet-activating factor (PAF)-like activity, localization of PAF receptor (PAF-R) and PAF-acetylhydrolase (PAF-AH) activity in bovine endometrium at different stages of the estrous cycle and early pregnancy. 2001 Prostaglandins Other Lipid Mediat. pmid:11403499
Elzi DJ et al. Ionomycin causes activation of p38 and p42/44 mitogen-activated protein kinases in human neutrophils. 2001 Am. J. Physiol., Cell Physiol. pmid:11401859
Roudebush WE and Diehl JR Platelet-activating factor content in boar spermatozoa correlates with fertility. 2001 Theriogenology pmid:11396471
Mi B and Maleczka RE A Nozaki-Hiyama-Kishi Ni(II)/Cr(II) coupling approach to the phomactins. 2001 Org. Lett. pmid:11388849
Liu XH et al. Platelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats. 2001 Pediatr. Res. pmid:11385142
Hirashima Y et al. Effect of a platelet-activating factor receptor antagonist, E5880, on cerebral vasospasm after aneurysmal subarachnoid hemorrhage--open clinical trial to investigate efficacy and safety. 2001 Neurol. Med. Chir. (Tokyo) pmid:11381675
Rosa MS et al. Platelet-activating factor (PAF) modulates peritoneal mouse macrophage infection by Leishmania amazonensis. 2001 Curr. Microbiol. pmid:11375661
Iwase M et al. Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor. 2001 Crit. Care Med. pmid:11373429
Tu W et al. [Influences of BN50739 on neutrophil elastase and phospholipase A2 in lung and tracheal mucosa of pigs with acute severe pancreatitis]. 2000 Zhonghua Jie He He Hu Xi Za Zhi pmid:11372382
Lee T et al. Differential regulation of three catalytic activities of platelet-activating factor (PAF)-dependent transacetylase. 2001 Arch. Biochem. Biophys. pmid:11368182
Ferland C et al. Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system. 2001 J. Leukoc. Biol. pmid:11358986
Taylor R et al. Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction. 2001 Clin. Sci. pmid:11352774
Wu C et al. Evidence for the autocrine induction of capacitation of mammalian spermatozoa. 2001 J. Biol. Chem. pmid:11350972
Wild MD and Roudebush WE Platelet-activating factor improves intrauterine insemination outcome. 2001 Am. J. Obstet. Gynecol. pmid:11349157